Monopar Therapeutics Inc.Monopar Therapeutics Inc.Monopar Therapeutics Inc.

Monopar Therapeutics Inc.

No trades
See on Supercharts

Price target

4.000.00 0.00%
The 2 analysts offering 1 year price forecasts for MNPR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to MNPR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

MNPR EPS for the last quarter is −0.13 USD despite the estimation of −0.16 USD. In the next quarter EPS is expected to reach −0.14 USD. Track more of Monopar Therapeutics Inc. financials and stay on top of what is up with the company.
According to analysts, MNPR price target is 4.00 USD with a max estimate of 6.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with MNPR news and stock market news.